Explore our news

17.03.2020

Coronavirus (COVID-19)

As STADA we are "Caring for people‘s health as a trusted partner"

12.03.2020

STADA delivers double-digit growth in 2019 as it invests to lead Consumer Healthcare and Generics core segments

05.03.2020

STADA closes acquisition of Walmark

Creating a winning portfolio for Central Europe

04.03.2020

STADA takes clear lead in Russian consumer healthcare sector

STADA has today closed a US$660 million transaction of a Russian brand portfolio from Takeda

03.03.2020

Dr. Stephan Eder is appointed as EVP of STADA Russia/CIS

Stephan Eder decides to join STADA mid-year ss Executive Vice President of Russia-CIS

24.02.2020

STADA acquires 15 well-established GSK brands

STADA becomes a major Consumer Healthcare player

10.02.2020

Aidan Fry joins STADA’s corporate communications team

STADA has appointed Aidan Fry as Director of External Communications

07.02.2020

STADA to acquire established OTC and food supplement portfolio in the Philippines

STADA’s Philippines portfolio is strengthened with FERN C

Grippostad® Complex TV-Spot

Die schnelle Lösung bei Erkältung.

Hoggar® Night TV Spot

Einfach gut schlafen.

Hedrin®

und aus die Laus!

Nizoral®

Zur Behandlung von Kopfschuppen.

Nizoral®

Zur Behandlung von Kopfschuppen.

STADA on YouTube

Get in touch

For Journalists

STADA Arzrneimittel AG
Media Relations
61118 Bad Vilbel

Phone: +49(0) 6101 603-165

Fax: +49(0) 6101 603-215

press@stada.de

For Customers, Business Partners & general inquiries

STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel

Phone: +49(0) 6101 603-0

Fax: +49(0) 6101 603-215

info@stada.de